Cellectar Biosciences (CLRB) PT Lowered to $15 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts CLRB Hot Sheet
Price: $2.43 -1.22%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Ladenburg Thalmann analyst Ahu Demir lowered the price target on Cellectar Biosciences (NASDAQ: CLRB) to $15.00 (from $50.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
- JPMorgan Downgrades ZTO Express (ZTO) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
